Transparency Market
Research identifies Merck & Co., Inc., Eli Lilly and Company,
Novartis AG, Pfizer, Inc., Amgen Inc., Novo Nordisk A/S, Lupin
Pharmaceuticals, Inc., and AstraZeneca as some of the leading players
operating in the global women’s health market. The market is highly
fragmented due to a strong presence of several local vendors. Mergers
and acquisitions, research and development, and product innovations
are expected to be some of the key strategies of these companies in
the forthcoming years. Beyond cancer, these companies are also
expected to focus on osteoporosis and conditions such as
endometriosis to tap into the market potential of both developing as
well as developed countries.
Request for
Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=214
According to
Transparency Market Research, the global women’s health market is
expected rise at a CAGR of 5.7% during the forecast period of 2017
and 2025 to climb up steadily from US$58.05 bn in 2016. Out of the
various treatments, the non-hormonal segment is expected to hold a
significant share in the overall market. The wide range of products
in addition to a strong pipeline are expected to favor the rise of
this segment. Regionally-speaking, the global market will be led by
North America due to growing government expenditure on healthcare.
The high incidence
of cancer is expected to be the key growth driver for the global
women’s health market. Cancer disease indication segment of the
global women’s health market is anticipated to hold major market
share owing to rising incidences of breast cancer globally. World
Cancer Research Fund International has ranked breast cancer as the
second most common cancer globally, with an addition of nearly 1.7
million new cases in 2012. This trend is likely to be a major driver
of the breast cancer therapeutics in the women’s health market,
which is anticipated to expand at a high CAGR during the forecast
period.
Enquiry for
discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=214
The market estimates
for the breast cancer therapeutics by geography are further supported
by the data from WCRF International for geographical variations in
survival trends in breast cancer across the globe. The study by WCRF
considered survival rates were for breast cancer patients who
underwent treatment and were alive for five years post diagnosis.
Demand for various treatments for women’s health will be high in
developed economies due to a high expenditure on healthcare.
Furthermore, better rate of awareness in these regions is also
expected to make a significant contribution to the overall market.
The alarming survival rates in developing parts of the world are also
expected to augment the demand for women’s health products in the
forthcoming years. Breast cancer incidence rates still remain higher
in developed countries. Strong presence of research and development
labs around the world have also been anticipated as key growth
drivers for the overall market.
On the flip side the
global women’s health market is expected to face a few challenges.
The potential side effects of using treatments under the umbrella of
women’s health market is dissuading buyers. Furthermore, a wide
market of alternative medicine for treating several health issues
that women face is also projected to have a negative impact on the
overall market in the near future. The intensifying wave of health
and witness, which is driving women to seek a holistic path toward a
better life is also expected to hamper market growth.
About Us
Transparency Market
Research (TMR) is a market intelligence company, providing global
business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants, use proprietary data sources
and various tools and techniques to gather, and analyze information.
Our business offerings represent the latest and the most reliable
information indispensable for businesses to sustain a competitive
edge.
Each TMR syndicated
research report covers a different sector - such as pharmaceuticals,
chemicals, energy, food & beverages, semiconductors, med-devices,
consumer goods and technology. These reports provide in-depth
analysis and deep segmentation to possible micro levels. With wider
scope and stratified research methodology, TMR’s syndicated reports
strive to provide clients to serve their overall research
requirement.
US Office
Contact
90 State Street,
Suite 700
Albany, NY 12207
Tel:
+1-518-618-1030
USA - Canada Toll
Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment